Clinical trial

Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01922271

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention NVA237 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Tiotropium Normalized identity: tiotropiumView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo to NVA237 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo to tiotropium Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Salbutamol Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-08-01

PhasePHASE4

Conditions

Chronic Obstructive Pulmonary Diseaseverified · MONDO: chronic obstructive pulmonary disease

Interventions

NVA237DRUG

TiotropiumDRUG · verified · RxNorm: tiotropium

Placebo to NVA237DRUG

Placebo to tiotropiumDRUG

SalbutamolDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

BerlinGermany4 HamburgGermany1 FrankfurtGermany1 LübeckGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01922271 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.